COVID-19 vaccination in haemodialysis patients: good things come in threes…
L. Frantzen, Sandrine Thibeaut, Julie Moussi‐Francès, Monica Indreies, Clotilde Kiener, Yannick Saingra, Julien Santini, Paul Stroumza, Yohan El-Haik, Guilhem Cavaillé
Abstract
Dialysis patients are particularly vulnerable to sudden acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, which justifies their priority access to vaccination in many countries. Even though their vaccine response level can be regarded as excellent (~90%), several studies [1-3] have nonetheless found antibody titres significantly lower than those observed in the general population. In this context, the French National Authority for Health recommends adjusting vaccination schedules in haemodialysis (HD) patients and administer a third dose.
Topics & Concepts
Coronavirus disease 2019 (COVID-19)Vaccination2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)MedicineVirologyPandemicIntensive care medicineInternal medicineOutbreakDiseaseInfectious disease (medical specialty)SARS-CoV-2 and COVID-19 ResearchVaccine Coverage and HesitancyCOVID-19 Clinical Research Studies